Lantheus Holdings, Inc. (LNTH) financial statements (2022 and earlier)

Company profile

Business Address 331 TREBLE COVE ROAD
NORTH BILLERICA, MA 01862
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments98,50891,47591,50068,86179,61287,99490,309
Cash and cash equivalents98,50891,47591,50068,86179,61287,99490,309
Receivables89,33664,05454,89258,99154,00249,20646,883
Inventory, net of allowances, customer advances and progress billings35,12933,94931,71930,35735,74437,62335,334
Inventory35,12933,94931,71930,35735,74437,62335,334
Disposal group, including discontinued operation    5,242  
Other current assets12,81812,0438,10210,1459,6259,7098,630
Total current assets:235,791201,521186,213168,354184,225184,532181,156
Noncurrent Assets
Intangible assets, net (including goodwill)409,699418,072426,448432,520434,644442,512447,277
Goodwill61,18961,18961,18961,18958,63257,76557,765
Intangible assets, net (excluding goodwill)348,510356,883365,259371,331376,012384,747389,512
Deferred income tax assets62,76466,49364,77762,83270,14769,34567,441
Other noncurrent assets38,75845,28961,87161,36160,63460,82460,918
Other undisclosed noncurrent assets116,772116,441118,493118,381120,171122,381122,903
Total noncurrent assets:627,993646,295671,589675,094685,596695,062698,539
TOTAL ASSETS:863,784847,816857,802843,448869,821879,594879,695
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities51,72120,50821,47119,09943,00724,07016,301
Accounts payable20,78720,50821,47119,09916,28424,07016,301
Accrued liabilities8,204   9,054  
Employee-related liabilities22,730   17,669  
Debt12,03410,35610,37210,25120,95018,13817,143
Disposal group, including discontinued operation    1,793  
Other undisclosed current liabilities26,74246,03941,98335,24014,75439,79242,892
Total current liabilities:90,49776,90373,82664,59080,50482,00076,336
Noncurrent Liabilities
Long-term debt and lease obligation, including:163,121166,741169,249171,474197,699204,669210,010
Long-term debt, excluding current maturities163,121  171,474197,699204,669210,010
Finance lease, liability 262     
Operating lease, liability 16,391     
Other undisclosed long-term debt and lease obligation 150,088169,249    
Liabilities, other than long-term debt145,727104,828106,58779,26577,41379,34677,766
Asset retirement obligations20,83315,18514,79714,40814,02013,96213,602
Other liabilities124,89489,64391,79064,85763,39365,38464,164
Total noncurrent liabilities:308,848271,569275,836250,739275,112284,015287,776
Total liabilities:399,345348,472349,662315,329355,616366,015364,112
Stockholders' equity
Stockholders' equity attributable to parent464,439499,344508,140528,119514,205513,579515,583
Common stock677677676674669668668
Additional paid in capital685,472680,819676,059669,623665,530661,955657,669
Accumulated other comprehensive loss(485)(1,142)(1,000)(1,240)(2,048)(2,510)(2,606)
Accumulated deficit(221,225)(181,010)(167,595)(140,938)(149,946)(146,534)(140,148)
Total stockholders' equity:464,439499,344508,140528,119514,205513,579515,583
TOTAL LIABILITIES AND EQUITY:863,784847,816857,802843,448869,821879,594879,695

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues129,562102,073101,06492,50994,15288,54466,010
Cost of revenue
(Cost of Goods and Services Sold)
(71,654)(59,404)(54,976)(51,479)(55,501)(52,284)(40,162)
Gross profit:57,90842,66946,08841,03038,65136,26025,848
Operating expenses(108,509)(56,997)(72,869)(25,408)(39,179)(41,510)(31,393)
Other undisclosed operating income15,263      
Operating income (loss):(35,338)(14,328)(26,781)15,622(528)(5,250)(5,545)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(4,141)(3,940)182549496596756
Interest and debt expense(1,528)(1,569)(1,937)(1,829)(2,811)(2,808)(1,914)
Income (loss) from continuing operations before income taxes:(41,007)(19,837)(28,536)14,342(2,843)(7,462)(6,703)
Income tax expense (benefit)7926,4221,879(5,334)(569)1,076(309)
Net income (loss) available to common stockholders, diluted:(40,215)(13,415)(26,657)9,008(3,412)(6,386)(7,012)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(40,215)(13,415)(26,657)9,008(3,412)(6,386)(7,012)
Comprehensive income (loss):(40,215)(13,415)(26,657)9,008(3,412)(6,386)(7,012)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent657(142)24080846296(212)
Comprehensive income (loss), net of tax, attributable to parent:(39,558)(13,557)(26,417)9,816(2,950)(6,290)(7,224)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: